Skip to main content
. Author manuscript; available in PMC: 2015 Aug 1.
Published in final edited form as: Ophthalmology. 2014 Apr 24;121(8):1547–1557.e1. doi: 10.1016/j.ophtha.2014.01.036

Table 4.

Number, Cumulative Kaplan-Meier percent (standard error) of Late (> 3 months) Postoperative Complications in the Ahmed Baerveldt Comparison Study

Complication Year 3 N, Cumulative proportion (SE) log-rank
p-value
Risk
Ratio*
95%
confidence
interval on
risk ratio
Ahmed Baerveldt
Tube occlusion 1, 0.8% (0.8%) 6, 4.9% (1.9%) 0.039 6.82 0.8 – 56.6
Choroidal effusion 0, 0.0% NA 2, 1.7% (1.2%) 0.15 ** **
Suprachoroidal hemorrhage 0, 0.0% NA 0, 0.0% NA NA ** **
Endophthalmitis 0, 0.0% NA 1, 0.8% (0.8%) 0.30 ** **
Cystoid Macular Edema 5, 4.1% (1.8%) 5, 4.8% (1.8%) 0.97 1.03 0.3 – 3.6
Shallow Anterior Chamber 1, 0.9% (0.9%) 3, 3.3% (1.9%) 0.27 3.31 0.3 – 31.8
Hypotony maculopathy 0, 0.0% NA 1, 0.8% (0.8%) 0.30 ** **
Diplopia 16, 11.9% (2.8%) 14, 11.2% (2.8%) 0.84 0.93 0.5 – 1.9
Corneal edema, All 14, 12.4% (3.1%) 15, 15.7% (3.7%) 0.51 1.3 0.6 – 2.7
  likely attributable to GDI 7, 6.4% (2.3%) 9, 10.1% (3.2%) 0.42 1.50 0.6 – 4.0
Tube-corneal touch 4, 3.2% (1.6%) 4, 3.5% (1.7%) 0.88 1.12 0.3 – 4.5
Corneal graft rejection 4, 3.5 (1.7%) 5, 4.6% (2.0%) 0.71 1.29 0.3 – 4.8
Band Keratopathy 0, 0.0% NA 1, 0.8% (0.8%) 0.31 ** **
Corneal neovascularization 0, 0.0% NA 1, 1.0% (1.0%) 0.33 ** **
Tube erosion 2, 1.5% (1.1%) 1, 0.9% (0.9%) 0.61 0.54 0.1 – 6.0
Encysted Bleb 1, 0.9% (0.9%) 0, 0.0% NA 0.32 ** **
Recurrent or persistent iritis 6, 5.1% (2.0%) 5 4.4% (1.9%) 0.81 0.87 0.3 – 2.8
Phthisis bulbi 0, 0.0% NA 5, 4.6% (2.0% 0.023 ** **
Hyphema 2, 1.5% (1.1%) 2, 1.6% (1.1%) 0.97 1.04 0.1 – 7.4
Vitreous hemorrhage 3, 2.7% (1.5%) 3, 2.5% (1.5%) 0.96 1.04 0.2 – 5.2
Pupillary membrane 1, 0.8% (0.8%) 0, 0.0% NA 0.33 ** **
Epiretinal membrane 0, 0.0% NA 1, 0.8% (0.8) 0.33 ** **
Retinal Detachment 2, 1.6% (1.1%) 2, 1.7% (1.2%) 0.98 1.02 0.1 – 7.2
Corneal blood staining 0, 0.0% NA 2, 1.6% (1.1%) 0.15 ** **
Anterior Synechiae 0, 0.0% NA 1, 1.0% (1.0%) 0.33 ** **
Total Patients with Late Complications 55, 44.7% (4.6%) 63, 51.5% (4.6%) 0.13 1.32 0.9 – 1.9

In the one year follow-up report, the complications of 4 eyes occurring after complications explant of the study device were included in percentages

*

Risk greater than 1.0 is associated with higher risk in eyes randomized to Baereldt Glaucoma Implant, a risk less than 1.0 is associated with a higher risk in eyes randomized to Ahmed Glaucoma Valve.

**

Cox proportional hazards model did not converge

After publication of the one year report, the Data and Safety Monitoring Committee decided that one case of endophthalmitis was due to a corneal transplant which occurred after implantation of the study shunt and that the necessity of performing the corneal transplant was due to pre-existing corneal disease and not the study shunt

SE = Standard Error, NA = Not applicable